TritonPoint Partners, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2111167 CHEVY CHASE, MD

Position in VRTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$350,691

New position

Shares Held

706

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#1,180

of 1,735 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

TritonPoint Partners, LLC holds $1,194,506 across 5 Biotechnology names. VRTX ranks #2 (29.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	619	$385,971
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	706	$350,691
3	IMMX	Immix Biopharma, Inc.	24,526	$252,863
4	ARCT	Arcturus Therapeutics Holdings Inc.	28,186	$189,409
5	CALC	CalciMedica, Inc.	15,119	$15,572

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$350,691	706	—	Shares	Sole	2026-08-13
No filing history on record for this holder in this stock.